What is Enliven Therapeutics, Inc. Common Stock's Market Cap?

Enliven Therapeutics, Inc. Common Stock's Market Cap is $3.0B, based on as-reported figures from SEC (XBRL) filings.

What is Enliven Therapeutics, Inc. Common Stock's Enterprise Value?

Enliven Therapeutics, Inc. Common Stock's Enterprise Value is $2.1B, based on as-reported figures from SEC (XBRL) filings.

What is Enliven Therapeutics, Inc. Common Stock's EV / EBITDA?

Enliven Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Enliven Therapeutics, Inc. Common Stock's Net Income (TTM)?

Enliven Therapeutics, Inc. Common Stock's Net Income (TTM) is -$105.9M, based on as-reported figures from SEC (XBRL) filings.

What is Enliven Therapeutics, Inc. Common Stock's EBITDA?

Enliven Therapeutics, Inc. Common Stock's EBITDA is -$124.2M, based on as-reported figures from SEC (XBRL) filings.

What is Enliven Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?

Enliven Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -1.45, based on as-reported figures from SEC (XBRL) filings.

What is Enliven Therapeutics, Inc. Common Stock's Net Debt?

Enliven Therapeutics, Inc. Common Stock's Net Debt is -$895.2M, based on as-reported figures from SEC (XBRL) filings.

AKYLA/ Financials

Equity / PHARMACEUTICAL PREPARATIONS

Enliven Therapeutics, Inc. Common Stock

XNAS · usd

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG00CP3BDF2

41.52▼ 0.41 (-0.98%)

As of 2026-10-23

Price / Volume

Valuation

Market Cap
Enterprise Value
Trailing P/E: —
Price / Sales: —
EV / Revenue: —
EV / EBITDA

Financial Highlights

Revenue (TTM): —
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin: —
Net Debt

Trading Information

Previous Close: 41.93
Day's Range: 40.82 – 41.64
52-Week Range: 14.79 – 62.32
Volume: 2.3M
Avg Volume: 1.6M

Share Statistics

Shares Outstanding
Employees: 60
Exchange: XNAS
Listed: 2023-02-24

Share count as of July 28, 2026

Enliven Therapeutics, Inc. Common Stock (ELVN) Financial Statements

View

Income Statement

Detail

Standard

Period

Quarterly

Loading Income Statement…

Key questions about Enliven Therapeutics, Inc. Common Stock (ELVN)

What is Enliven Therapeutics, Inc. Common Stock's Market Cap?: Enliven Therapeutics, Inc. Common Stock's Market Cap is $3.0B, based on as-reported figures from SEC (XBRL) filings.
What is Enliven Therapeutics, Inc. Common Stock's Enterprise Value?: Enliven Therapeutics, Inc. Common Stock's Enterprise Value is $2.1B, based on as-reported figures from SEC (XBRL) filings.
What is Enliven Therapeutics, Inc. Common Stock's EV / EBITDA?: Enliven Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Enliven Therapeutics, Inc. Common Stock's Net Income (TTM)?: Enliven Therapeutics, Inc. Common Stock's Net Income (TTM) is -$105.9M, based on as-reported figures from SEC (XBRL) filings.
What is Enliven Therapeutics, Inc. Common Stock's EBITDA?: Enliven Therapeutics, Inc. Common Stock's EBITDA is -$124.2M, based on as-reported figures from SEC (XBRL) filings.
What is Enliven Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?: Enliven Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -1.45, based on as-reported figures from SEC (XBRL) filings.
What is Enliven Therapeutics, Inc. Common Stock's Net Debt?: Enliven Therapeutics, Inc. Common Stock's Net Debt is -$895.2M, based on as-reported figures from SEC (XBRL) filings.

Akyla / Financials · ELVNAs-filed SEC (XBRL) data